HealthcareMid capRs 11,548 crRs 13.4 cr traded a day
Close on 2026-08-21
556.95
+2.99%
52-week range77% of the way up
421.75596.45
Market cap
11,548 cr
P/E (TTM)
56.9×
industry 44×
EPS (TTM)
9.78
Revenue YoY
+16.6%
Q1 FY27
Profit YoY
+25.7%
Net margin
12.6%
+0.9pt vs a year ago
Growth trend
-6.4pt
vs last quarter’s YoY
1 month
-1.9%
Below 52w high
7.1%
RSI (14)
34
Daily swing
3.4%
average true range
Volume
1.7×
vs 20-day average
Traded
Rs 13 cr
median day
Close200-day averageMaterial filing
260 sessions · hover for the filing behind a move
1 week
+2.10%
1 month
−1.85%
3 months
+2.98%
6 months
+17.84%
1 year
+2.36%
The read
written from the numbers on this page
The evidence leans constructive5 supporting, 1 against, 1 worth knowing
Supporting
trading 11% above its 200-day average
up 2% over twelve months
matches trading far more than usual, which has beaten the market by +0.45 points over 20 sessions across 52,251 past signals
5 independent kinds of evidence agree today, which is uncommon
revenue grew 17% year on year in the quarter ending 2026-06-30
Against
priced at 57× earnings against an industry median of 44× — 29% above its peers
Worth knowing
the 50-day and 200-day averages disagree, which usually means a turn in progress rather than a trend to lean on
What would change this read: a close below 502, its 200-day average.
Assembled automatically from the figures on this page — the scans matched, their measured record, the filed financials, the derivatives positioning and the peer comparison. It is not a recommendation, no one has spoken to the company, and every claim above can be checked against a number further down this page.
What is working, what is not
read from the filings, with the figure behind every line
Working3
Profit rose year on year in all 4 of the last 4 quarters.
4
Net profit +25.7% year on year, Rs 45 cr to Rs 57 cr.
+25.7%Rs 45 crRs 57 cr
Revenue +16.6% year on year, Rs 386 cr to Rs 450 cr.
+16.6%Rs 386 crRs 450 cr
Needs watching
Nothing in the filings stands out either way.
Every figure here is computed from the company’s own filings. The wording is generated directly from the figures.
How it has performed
price return over each window, measured against zero
What the scans say today
7 of 47 matched on 2026-08-21
METROPOLIS matches 7 of the 47 scans today, across 5 different kinds of evidence. Three or more independent families agreeing is uncommon — it is the same test the shortlist on every page uses.
METROPOLIS trades at 57× trailing earnings, below its median of 62× over this window — 8% less expensive than usual. The band runs from the 5th to the 95th percentile, so single-day spikes do not set the edges.
This window is short by the standards of valuation history — it begins where four quarters of filed earnings first exist. A stock can look cheap against two years and expensive against ten.
Other filing filings were typically -0.08pt vs the market over the next 5 sessions (n=12,093) · Analyst call filings were typically +0.14pt vs the market over the next 5 sessions (n=3,352) · AGM / EGM filings were typically +0.00pt vs the market over the next 5 sessions (n=4,362)
The business
from the company’s filed results
Everything below is taken from the company’s own quarterly filing with the exchange — the XBRL document it submitted, not a vendor’s summary of it. Figures in rupees crore.
RevenueNet profit, drawn inside its revenue barNet margin, own scale belowrupees crore, per quarter as filed. Revenue bars start at zero.
Going for it
revenue grew 17% against the same quarter a year earlier
profit rose 26% year on year
net margin widened from 12.0% to 12.6%
revenue rose in 3 of the last 4 quarters
Going against it
nothing clear in the filed numbers
Quarter-by-quarter numbers, as filed
Quarter
Revenue
Profit before tax
Net profit
EPS
Net margin
Q1 FY27
2026-06-30 · consolidated
450
78
57
2.73
12.6%
Q4 FY26
2026-03-31 · consolidated
425
70
51
2.46
12.0%
Q3 FY26
2025-12-31 · consolidated
406
57
42
7.99
10.4%
Q2 FY26
2025-09-30 · consolidated
429
71
53
10.17
12.3%
Q1 FY26
2025-06-30 · consolidated
386
61
45
8.70
11.7%
Q4 FY25
2025-03-31 · consolidated
345
36
29
5.69
8.5%
Quarterly filings are unaudited unless stated. Consolidated figures are used where the company files both. A single quarter is a noisy thing — the trend across the column is worth more than the top row.
Where the price stands
the same figures every scan on this site is computed from
Trend
Distance from the averages traders watch. Above all of them is a bull phase; below the 200-day is the line most investors use to say otherwise.
Versus 50-day average-0.5%
Versus 200-day average+11.0%
Below 52-week high-6.6%
Above 52-week low+32.1%
Momentum
How hard it has been pushed lately. Above 70 on RSI is stretched, below 30 is washed out — neither is a signal on its own.
RSI (14)33.8
Higher closes in last 54 of 5
Six-month return+17.84%
Risk and liquidity
What a position costs to hold and to exit. Position sizing starts with the daily swing, not with conviction.
Typical daily swing (ATR)3.42%
Volume versus 20-day1.7x
Median daily turnoverRs 13.4 cr
Peers
Healthcare · 67 classified companies
METROPOLIS trades at 56.9× trailing earnings against an industry median of 44.0× across 64 other classified companies in its industry — more expensive than them, by 29%. A multiple is a statement about expectations, not about quality: cheap usually means the market expects less, and it is often right.
largest twelve by market capitalisation. Market cap and P/E need filed financials, so blanks are companies whose filings have not been read yet
Recent sessions
what this stock has matched since the engine went live
This is the live record, not the backtest — the scans this stock actually appeared in on each stored session. A name that keeps reappearing is in a persistent condition; a one-day appearance usually is not.